Hypertension in Low- and Middle-Income Countries
The ICHOM Standard Set for Hypertension in Low- and Middle-Income Countries is the result of hard work by a group of leading physicians, measurement experts and patients. It is our recommendation of the outcomes that matter most to patients with Hypertension in Low- and Middle-Income Countries. We urge all providers around the world to start measuring these outcomes to better understand how to improve the lives of their patients.
- Recorded via the Beliefs about Medicine Questionnaire (BMQ [BMQ-Specific section]).
- Includes physical activity (recommended to track via the International Physical Activity Questionnaire [IPAQ-Short Form]), medication adherence (recommended to track via the Hill-Bone Compliance to High Blood Pressure Therapy Scale – South Africa Version [Medication taking sub-scale]) and salt intake (recommended to track via the WHO STEPS Instrument).
- Includes survival (overall and cardiovascular), blood pressure control, hypertensive urgencies and hypertensive emergencies, and erectile function (recommended to track via PROMIS single question).
- Includes hospitalization, peripheral artery disease, hypertensive crisis, heart failure, ischaemic heart disease, cerebrovascular disease, atrial fibrillation, and renal disease
- Recommended to track via the EQ-5D.
Hypertension in Low- and Middle-Income Countries community group
The ICHOM Standard Set for Hypertension in Low- and Middle-Income Countries is the result of hard work by a group of leading physicians, measurement experts and patients.
Team that developed this standard
BELARUS
Vladislav Podpalov | Belarusian Hypertension Society, Vitebsk State Medical University
BRAZIL
Otavio Berwanger | Hospital do Coração
Celso Amodeo | Brazilian Society of Cardiology
CAMEROON
Anastase Dzudie Tamdja | Pan African Society of Cardiology, University of Yaounde
CANADA
Norman Campbell | University of Calgary
Ernesto Schiffrin | McGill University, Jewish General Hospital
GHANA
Peter Lamptey | London School of Hygiene and Tropical Medicine, FHI 360
INDIA
Raghupathy Anchala | Indian Institute of Public Health Hyderabad, Public Health Foundation of India
MALAYSIA
Yook-Chin Chia | University of Malaya, Institute for Healthcare Development at Sunway University, Malaysian Society of Hypertension
MOZAMBIQUE
Albertino Damasceno | Eduardo Mondlane University
PORTUGAL
Manuela Fiuza | Universidade de Lisboa
António Vaz Carneiro | Universidade de Lisboa
SWITZERLAND
Fareed Mirza | Novartis Foundation
UNITED KINGDOM
Dorothea Nitsch | London School of Hygiene and Tropical Medicine
UNITED STATES OF AMERICA
Gbenga Ogedegbe | New York University Langone Medical Center
VIETNAM
Nam Phuong Do Thi | Heart Institute of Ho Chi Minh City
*Two patient representatives from Mexico and Tanzania were also members of the Working Group.
